Munich, Germany

Roberto Falkenstein

USPTO Granted Patents = 24 

 

 

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 22(Granted Patents)


Location History:

  • Penzberg, DE (2023)
  • Munich, DE (2009 - 2024)

Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Roberto Falkenstein in Protein Purification

Introduction: Roberto Falkenstein, based in Munich, Germany, is a notable inventor with a remarkable portfolio of 21 patents. His work primarily focuses on methods for the purification of proteins, especially within the biomedical sector. His contributions have significantly advanced the field of recombinant protein purification and filtration technologies.

Latest Patents: Among his latest inventions are two notable patents. The first is a method for purifying PEGylated erythropoietin. This innovative approach utilizes cation exchange chromatography to separate the protein from reaction by-products and unreacted starting materials. It emphasizes the effectiveness of using Toyopearl® SP-650 chromatography material along with a two-step washing process, achieving high purity and yield suitable for large-scale applications. The second patent outlines a multistep final filtration method designed for concentrated polypeptide solutions. This method includes consecutive filtration steps utilizing filters of varying pore sizes, thereby enhancing the efficiency and effectiveness of the filtration process.

Career Highlights: Roberto has made significant contributions while working with esteemed companies in the pharmaceutical industry, namely Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His expertise and innovative thinking have played a critical role in developing cutting-edge biotechnology processes and products.

Collaborations: Throughout his career, Roberto has collaborated with other skilled professionals in the field, including Claudia Giessel and Klaus Schwendner. These collaborations have likely fostered innovative ideas and facilitated the successful execution of complex projects in protein purification.

Conclusion: Roberto Falkenstein's innovative work in the biotechnology sector demonstrates the importance of advancing methods for protein purification and filtration. His contributions not only enhance the efficiency of these processes but also pave the way for the development of high-purity products necessary for various biomedical applications. With a strong foundation in scientific research and collaboration, Roberto continues to make significant impacts through his inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…